---
schema_version: "secwatch.filing_event.v1"
accession: "0001757898-24-000014"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:21:28.906540+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# STERIS Q1 FY2025 revenue $1.3B (+8%), adjusted EPS $2.03; guidance reiterated

## Summary
- Total revenue from continuing ops $1.3B, up 8% YoY; constant currency organic revenue up 6%.
- As-reported EPS $1.41 (from $1.31), adjusted EPS $2.03 (from $1.84).
- Healthcare revenue +10% to $901.2M; AST +7% to $249.8M; Life Sciences -2% to $128.5M due to CECS divestiture.
- Segment operating income all up: Healthcare $216.9M, AST $117.7M, Life Sciences $52.6M.
- FY2025 guidance reaffirmed: rev growth 6.5-7.5%, adjusted EPS $9.05-$9.25, free cash flow ~$700M.

## SEC filing metadata
- accession: 0001757898-24-000014
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000014/0001757898-24-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000014/ste-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757898-24-000014
- JSON: https://secwatch.observer/filing/0001757898-24-000014.json
- Plain text: https://secwatch.observer/filing/0001757898-24-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.